A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LST / leishmanin skin test

[Related PubMed/MEDLINE]
Total Number of Papers: 92
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LST  (>> Co-occurring Abbreviation)
Long Form:   leishmanin skin test
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Prevalence of Cutaneous Leishmaniasis in Western Highlands in Yemen. CL
2018 A cross-sectional study of the filarial and Leishmania co-endemicity in two ecologically distinct settings in Mali. DTH, ICT
2018 Age trends in asymptomatic and symptomatic Leishmania donovani infection in the Indian subcontinent: A review and analysis of data from diagnostic and epidemiological studies. ISC, VL
2018 CD45RO+ T Cells and T Cell Activation in the Long-Lasting Immunity after Leishmania infantum Infection. RecVL, SLA, sVL, VL
2018 Histological and Immunological Description of the Leishmanin Skin Test in Ibizan Hounds. DTH, TLR
2018 Immunity Against Leishmania major Infection: Parasite-Specific Granzyme B Induction as a Correlate of Protection. GrzB, PBMC, ZCL
2018 Impact of insecticide-treated bednets and indoor residual spraying in controlling populations of Phlebotomus duboscqi, the vector of Leishmania major in Central Mali. CL, IRS, LLINs
2018 Molecular Identification of Leishmania spp. DNA from Archived Giemsa-Stained Slides of Patients from Salta, Argentina. PCR, RFLP
2017 Evaluation of IL-12RB1, IL-12B, CXCR-3 and IL-17a expression in cases affected by a non-healing form of cutaneous leishmaniasis: an observational study design. CL, CXCL, CXCR, IFN, IL, NHCL, PBMCs
10  2017 Human cellular and humoral immune responses to Phlebotomus papatasi salivary gland antigens in endemic areas differing in prevalence of Leishmania major infection. CL, SGE
11  2017 Reappraisal of Leishmanin Skin Test (LST) in the management of American Cutaneous Leishmaniasis: A retrospective analysis from a reference center in Argentina. ---
12  2016 Epidemiology of the outbreak, vectors and reservoirs of cutaneous leishmaniasis in Mali: A systematic review and meta-analysis. CL
13  2016 Genome-Wide Association Study of Cell-Mediated Response in Dogs Naturally Infected by Leishmania infantum. CanL, CMI, GWAS, IFN-gamma, IL-10, LPA, SNPs, TGF-beta, TNF-alpha
14  2016 Immunologic Markers of Protection in Leishmania (Viannia) braziliensis Infection: A 5-Year Cohort Study. CL, HCs, IFN, SC
15  2016 Prevalence of Cutaneous Leishmaniasis in Districts of High and Low Endemicity in Mali. CL
16  2016 Protein biomarkers discriminate Leishmania major-infected and non-infected individuals in areas endemic for cutaneous leishmaniasis. PCA
17  2016 Risk Factors Associated with Human Visceral Leishmaniasis in an Urban Area of Bahia, Brazil. PR, VL
18  2015 Parasitological Confirmation and Analysis of Leishmania Diversity in Asymptomatic and Subclinical Infection following Resolution of Cutaneous Leishmaniasis. CL
19  2014 Co-existence of cutaneous leishmaniasis with pleural effusion: a case report from Iran. H&E, PCR, PPD
20  2014 Epidemiology of visceral leishmaniasis in Georgia. VL
21  2014 Prevalence and determinants of Leishmania major infection in emerging and old foci in Tunisia. L. major, ZCL
22  2014 Whole blood assay and visceral leishmaniasis: Challenges and promises. PBMCs, SLA, VL, WBA
23  2013 A FRET-based real-time PCR assay to identify the main causal agents of New World tegumentary leishmaniasis. MLST, NWTL, PCR
24  2013 Evaluation of leishmanin skin test reaction in different variants of cutaneous leishmaniasis. CL
25  2013 Immunologic response and memory T cells in subjects cured of tegumentary leishmaniasis. CL, ML, SLA
26  2013 Post-Kala-Azar Dermal Leishmaniasis: A Paradigm of Paradoxical Immune Reconstitution Syndrome in Non-HIV/AIDS Patients. IRISs, PKDL, VL
27  2013 Reevaluating leishmanin skin test as a marker for immunity against cutaneous leishmaniasis. ---
28  2012 Age related efficiency of the leishmanin skin test as a marker of immunity to human visceral leishmaniasis. IFN-gamma, SLA
29  2012 Assessment of interferon-gamma levels and leishmanin skin test results in persons recovered for leishmaniasis. IFN-gamma
30  2012 Factors associated with Leishmania asymptomatic infection: results from a cross-sectional survey in highland northern Ethiopia. ---
31  2012 IFN-gamma production to leishmania antigen supplements the leishmania skin test in identifying exposure to L. braziliensis infection. DTH, HC, SLA
32  2012 Immunobiology of visceral leishmaniasis. PBMC, VL
33  2012 Leishmania infantum chagasi in northeastern Brazil: asymptomatic infection at the urban perimeter. VL
34  2011 Comparison of leishmanin skin test and direct smear for the diagnosis of cutaneous leishmaniasis. CL
35  2011 Development of cutaneous leishmaniasis after leishmania skin test. CL, IFN-gamma, TNF-alpha
36  2011 Non-invasive cytology brush PCR diagnostic testing in mucosal leishmaniasis: superior performance to conventional biopsy with histopathology. ML
37  2011 Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control. VL
38  2010 Clinical and demographic stratification of test performance: a pooled analysis of five laboratory diagnostic methods for American cutaneous leishmaniasis. CI, PCR
39  2010 Humoral and in vivo cellular immunity against the raw insect-derived recombinant Leishmania infantum antigens KMPII, TRYP, LACK, and papLe22 in dogs from an endemic area. DTH, rKMPII
40  2009 A cross-sectional study on the clinical and immunological spectrum of human Leishmania (L.) infantum chagasi infection in the Brazilian Amazon region. AI, AVL, SOI, SRI
41  2009 A longitudinal study on the transmission dynamics of human Leishmania (Leishmania) infantum chagasi infection in Amazonian Brazil, with special reference to its prevalence and incidence. AVL, IFAT
42  2009 Discrepant prevalence and incidence of Leishmania infection between two neighboring villages in Central Mali based on Leishmanin skin test surveys. CL, OR
43  2009 Evaluation of leishmanin skin test in Indian visceral leishmaniasis. HEC, VL
44  2009 Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials. IL-10
45  2009 Leishmania OligoC-TesT as a simple, rapid, and standardized tool for molecular diagnosis of cutaneous leishmaniasis in Peru. CI, CL
46  2009 Visceral leishmaniasis in Aba-Roba, south-western Ethiopia: prevalence and incidence of active and subclinical infections. DAT, VL
47  2008 Associations among immunological, parasitological and clinical parameters in canine visceral leishmaniasis: Emaciation, spleen parasitism, specific antibodies and leishmanin skin test reaction. ---
48  2008 Detection of Leishmania infantum kinetoplast DNA in the whole blood of asymptomatic individuals by PCR-ELISA and comparison with other infection markers in endemic areas, southern Iran. IFAT, kDNA, PCR, VL
49  2008 Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment. PKDL, SSG
50  2007 Exposure to Leishmania major modulates the proportion of CD4+ T cells without affecting cellular immune responses. PRL
51  2007 Leishmania-specific isotype levels and their relationship with specific cell-mediated immunity parameters in canine leishmaniasis. CMI, IFN, LPA
52  2006 Evaluation of leishmanin skin test and its relationship with the clinical form and duration of cutaneous leishmaniasis. ---
53  2006 Loss of leishmanin skin test antigen sensitivity and potency in a longitudinal study of visceral leishmaniasis in Bangladesh. ---
54  2006 Sensitivity of leishmanin skin test in patients of acute cutaneous leishmaniasis. CL
55  2006 Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors. DAT, OR, VL
56  2005 Comparison of three assays for the evaluation of specific cellular immunity to Leishmania infantum in dogs. IFNB, LPA
57  2005 Dichotomy of protective cellular immune responses to human visceral leishmaniasis. BCG, CL, IL, PBMCs, VL
58  2005 Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia. CL
59  2005 Longitudinal study of dogs living in an area of Spain highly endemic for leishmaniasis by serologic analysis and the leishmanin skin test. ---
60  2005 The burden of the Leishmania chagasi/infantum infection in a closed rural focus of visceral leishmaniasis in Lara state, west-central Venezuela. IFAT, OR, VL
61  2005 The predictive validity of naturally acquired delayed-type hypersensitivity to leishmanin in resistance to Leishmania major-associated cutaneous leishmaniasis. ZCL
62  2004 Infection rates with Leishmania donovani and Mycobacterium tuberculosis in a village in eastern Sudan. TB, VL
63  2004 Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis. CL
64  2003 Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guerrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers. ALM, BCG, DTH
65  2003 Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG. ALM, BCG, CL, IFN-gamma, IL
66  2003 Randomized, double-blind, placebo-controlled study on the immunogenicity of the leishmanin skin test. ---
67  2002 Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. ---
68  2002 Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan. CL, PKDL, VL
69  2002 Epidemiology of visceral leishmaniasis in Atbara River area, eastern Sudan: the outbreak of Barbar El Fugara village (1996-1997). DAT, PKDL, VL
70  2002 The effect of repeated leishmanin skin testing on the immune responses to Leishmania antigen in healthy volunteers. ---
71  2002 The natural history of Sudanese post-kala-azar dermal leishmaniasis: clinical, immunological and prognostic features. DAT, PKDL, VL
72  2001 A randomized double-blind placebo-controlled trial to evaluate the immunogenicity of a candidate vaccine against American tegumentary leishmaniasis. ---
73  2001 Association analysis of HLA-class II and class III gene polymorphisms in the susceptibility to mediterranean visceral leishmaniasis. MVL
74  2001 Leishmaniasis in Sudan. Visceral leishmaniasis. DAT, IL, PKDL, VL
75  2000 Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis. PKDL
76  1999 Evaluation of a standardized leishmanin skin test in Guatemala. CL
77  1999 Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis. PBMC
78  1999 Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia. IFN-gamma, LCL, PBMC
79  1998 Epidemiologic characterization of American cutaneous leishmaniasis in an endemic region of eastern Venezuela. ---
80  1998 Leishmaniasis in the middle course of the Ethiopian Rift Valley: I. Clinical and leishmanin skin test surveys. CL, VL
81  1998 Response to heterologous leishmanins in cutaneous leishmaniasis in Nigeria--discovery of a new focus. CL
82  1998 rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection. DAT, ELISA
83  1998 The re-emergence of American visceral leishmaniasis in an old focus in Venezuela: present situation of human and canine infections. AVL, CIEP, IFAT
84  1997 Use of Leishmania major derived leishmanin for skin test surveys of visceral leishmaniasis in Ethiopia. LCL, VL
85  1997 Use of PCR on lymph-node sample as test of cure of visceral leishmaniasis. PCR, PKDL
86  1996 Leishmaniasis eco-epidemiology in the Alpujarra region (Granada Province, southern Spain). ---
87  1995 Serodiagnosis of leishmaniasis. DAT, ELISA, PKDL, VL
88  1994 Studies on the prevalence of leishmanin skin test positivity in the Baringo District, Rift Valley, Kenya. VL
89  1993 A clinical prediction rule for American cutaneous leishmaniasis in Colombia. ACL
90  1993 Environmental manipulation in the control of a zoonotic cutaneous leishmaniasis focus. ZCL
91  1993 Epidemiology of cutaneous leishmaniasis in Colombia: a longitudinal study of the natural history, prevalence, and incidence of infection and clinical manifestations. ---
92  1991 Leishmanin skin test standardization and evaluation of safety, dose, storage, longevity of reaction and sensitization. ---